Asthmatx Acquisition By Boston Scientific Is Source of Many Happy Returns
Executive Summary
Boston Scientific's acquisition of Asthmatx marks a return of the company to the field of strategic buyers with the deal, and in picking Asthmatx, BSX is is reversing a decision it made two years when it sold off its strategic stake in the asthma-device company.
You may also be interested in...
Despite Setbacks, Emphysema Devices Find Funding
Minimally invasive emphysema devices have seen their ups and downs over the years, but despite technological and regulatory challenges, VCs continue to fund these devices, with investments driven by the market opportunity, huge unmet clinical need, and promising technologies.
Rox Gets Blood Pumping in COPD
Rox Medical is taking an unusual approach to treating COPD by introducing a vascular device that increases oxygen delivery to tissue and cardiac output. The potential has investors' hearts racing as well.
Rox Gets Blood Pumping in COPD
Rox Medical is taking an unusual approach to treating COPD by introducing a vascular device that increases oxygen delivery to tissue and cardiac output. The potential has investors' hearts racing as well.